IDM Pharma, Inc. (IDMI)

[bowonwing]

IDM should have sold for $16.56 a share. Thank you for sharing this tzm. Filing looks like an attempt to show Walbert and B of D in "good faith" made the best deal the IDM shareholders, kind of a CYA. It does appear that one lawsuit was settled and another withdrawn, but apparently without prejudice, which means the plaintiff could re-file it.

If I am reading this document right, this is the first figures put forth projecting costs/revenue/EBITDA for Mepact in the EU. Their figures prove <$68M for IDM at $2.64 a share is a crime.

The est. for revenue from 2009 to 2013, five years is: $138M. Thus using x3 revs for next five years IDM should have sold for $414M; at 25M shares= $16.56 a share!

Furthermore what is amazing are the EBITDA est. in millions:
2009: $(23)
2010: (7)
2011: 7
2012: 28
2013: 33
2014: 35
2015: 37
2016: 41
2017: 43
2018: 45
2019: 49 it goes on but I am stopping here.

Thus projected EBITDA for next tens years in EU alone is: $288M!
From 2009 to 2013, five years is: $38M.